Stocksigma LogoStocksigma Logo

Max Healthcare Q2 FY27 Results and Expansion Approvals

Max Healthcare Institute reported consolidated revenue from operations of ₹2,56,921 lakh for the quarter ended 30th Sep'26, up 20.31% YoY, with net profit

Max Healthcare Q2 FY27 Results and Expansion Approvals

Max Healthcare Institute Ltd · Change in Management · 30 Oct 2026, 8:27 pm

Max Healthcare Q2 FY27 Results and Expansion Approvals Max Healthcare Institute reported consolidated revenue from operations of ₹2,56,921 lakh for the quarter ended 30th Sep'26, up 20.31% YoY, with net profit after tax reaching ₹41,445 lakh (PAT attributable to owners at ₹41,494 lakh). The board approved capex via subsidiary Crosslay Remedies: ~₹93 crore to add ~85 beds at MSSH Noida within 15 months, and ~₹97 crore to add ~60 beds at MSSH Vaishali within 24 months. Additionally, the Sector-56 Gurugram hospital project cost was revised to ~₹1,143 crore, targeted for completion by Apr'27.

Original exchange filing (PDF)

More announcements from Max Healthcare Institute Ltd

All Max Healthcare Institute Ltd announcements